These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 10976001)

  • 1. An IL-6/IL-6 soluble receptor (IL-6R) hybrid protein (H-IL-6) induces EPO-independent erythroid differentiation in human CD34(+) cells.
    Baiocchi M; Marcucci I; Rose-John S; Serlupi-Crescenzi O; Biffoni M
    Cytokine; 2000 Sep; 12(9):1395-9. PubMed ID: 10976001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Signal through gp130 activated by soluble interleukin (IL)-6 receptor (R) and IL-6 or IL-6R/IL-6 fusion protein enhances ex vivo expansion of human peripheral blood-derived hematopoietic progenitors.
    Kimura T; Wang J; Minamiguchi H; Fujiki H; Harada S; Okuda K; Kaneko H; Yokota S; Yasukawa K; Abe T; Sonoda Y
    Stem Cells; 2000; 18(6):444-52. PubMed ID: 11072033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neutralization of autocrine transforming growth factor-beta in human cord blood CD34(+)CD38(-)Lin(-) cells promotes stem-cell-factor-mediated erythropoietin-independent early erythroid progenitor development and reduces terminal differentiation.
    Akel S; Petrow-Sadowski C; Laughlin MJ; Ruscetti FW
    Stem Cells; 2003; 21(5):557-67. PubMed ID: 12968110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of IL-6/sIL-6R on ex vivo expansion of human cord blood derived CD34+ cells].
    Feng JF; Zhuang M; Zhu LJ; Sheng ZL; Zhu YQ; Li CP
    Ai Zheng; 2004 Jun; 23(6):715-8. PubMed ID: 15191679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The regulatory role of Hyper-IL-6 in the differentiation of myeloid and erythroid progenitors derived from human cord blood.
    Yu Z; Liu W; Liu D; Fan L
    Cell Immunol; 2006 May; 241(1):32-7. PubMed ID: 16934790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ultrastructural and phenotypic analysis of in vitro erythropoiesis from human cord blood CD34+ cells.
    Kie JH; Jung YJ; Woo SY; Ryu KH; Park HY; Chung WS; Seoh JY
    Ann Hematol; 2003 May; 82(5):278-83. PubMed ID: 12679887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Erythroid progenitors differentiate and mature in response to endogenous erythropoietin.
    Sato T; Maekawa T; Watanabe S; Tsuji K; Nakahata T
    J Clin Invest; 2000 Jul; 106(2):263-70. PubMed ID: 10903342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [EPO mediated proliferation and differentiation of human erythroid progenitor inhibited by FK228].
    Yu ZC; Liu WC; Fan L; Oishi K; Katayama N
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Jun; 23(6):575-7. PubMed ID: 17553359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A small-scale serum-free liquid cell culture model of erythropoiesis to assess the effects of exogenous factors.
    Cheung JO; Casals-Pascual C; Roberts DJ; Watt SM
    J Immunol Methods; 2007 Jan; 319(1-2):104-17. PubMed ID: 17174973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-6 receptor-interleukin-6 fusion proteins with enhanced interleukin-6 type pleiotropic activities.
    Chebath J; Fischer D; Kumar A; Oh JW; Kolett O; Lapidot T; Fischer M; Rose-John S; Nagler A; Slavin S; Revel M
    Eur Cytokine Netw; 1997 Dec; 8(4):359-65. PubMed ID: 9459615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recruitment of primitive peripheral blood cells: synergism of interleukin 12 with interleukin 6 and stem cell factor.
    Grafte-Faure S; Leveque C; Vasse M; Soria C; Vannier JP
    Br J Haematol; 1999 Apr; 105(1):33-9. PubMed ID: 10233360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Megakaryocytopoiesis in vitro: from the stem cells' perspective.
    Cardier JE; Foster DC; Lok S; Jacobsen SE; Murphy MJ
    Stem Cells; 1996; 14 Suppl 1():163-72. PubMed ID: 11012217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Erythropoietin-dependent suppression of the expression of the beta subunits of the interleukin-3 receptor during erythroid differentiation.
    Carta C; Campisi S; Migliaccio G; Migliaccio AR
    Blood Cells Mol Dis; 2000 Oct; 26(5):467-78. PubMed ID: 11112384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decrease in apoptosis and increase in polyploidization of megakaryocytes by stem cell factor during ex vivo expansion of human cord blood CD34+ cells using thrombopoietin.
    Kie JH; Yang WI; Lee MK; Kwon TJ; Min YH; Kim HO; Ahn HS; Im SA; Kim HL; Park HY; Ryu KH; Chung WS; Shin MH; Jung YJ; Woo SY; Park HK; Seoh JY
    Stem Cells; 2002; 20(1):73-9. PubMed ID: 11796924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone morphogenetic proteins act synergistically with haematopoietic cytokines in the differentiation of haematopoietic progenitors.
    Detmer K; Walker AN
    Cytokine; 2002 Jan; 17(1):36-42. PubMed ID: 11886169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel protocol that allows short-term stem cell expansion of both committed and pluripotent hematopoietic progenitor cells suitable for clinical use.
    Astori G; Malangone W; Adami V; Risso A; Dorotea L; Falasca E; Marini L; Spizzo R; Bigi L; Sala P; Tonutti E; Biffoni F; Rinaldi C; Del Frate G; Pittino M; Degrassi A
    Blood Cells Mol Dis; 2001; 27(4):715-24; discussion 725-7. PubMed ID: 11778655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pleiotropic role of histone deacetylases in the regulation of human adult erythropoiesis.
    Yamamura K; Ohishi K; Katayama N; Yu Z; Kato K; Masuya M; Fujieda A; Sugimoto Y; Miyata E; Shibasaki T; Heike Y; Takaue Y; Shiku H
    Br J Haematol; 2006 Oct; 135(2):242-53. PubMed ID: 16939493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro clinical-grade generation of red blood cells from human umbilical cord blood CD34+ cells.
    Baek EJ; Kim HS; Kim S; Jin H; Choi TY; Kim HO
    Transfusion; 2008 Oct; 48(10):2235-45. PubMed ID: 18673341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination therapy with interleukin-6 receptor superantagonist Sant7 and dexamethasone induces antitumor effects in a novel SCID-hu In vivo model of human multiple myeloma.
    Tassone P; Neri P; Burger R; Savino R; Shammas M; Catley L; Podar K; Chauhan D; Masciari S; Gozzini A; Tagliaferri P; Venuta S; Munshi NC; Anderson KC
    Clin Cancer Res; 2005 Jun; 11(11):4251-8. PubMed ID: 15930364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of cytokine interactions by flow cytometry and factorial analysis.
    Case J; Rice A; Wood J; Gaudry L; Vowels M; Nordon RE
    Cytometry; 2001 Jan; 43(1):69-81. PubMed ID: 11122486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.